ECEric C. Cheon

Eric C. Cheon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eric C. Cheon has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Potential Mitochondrial Pharmacogenetic Susceptibility to Severe Neurologic Events after General Anesthesia: Comment

    by JonathanM. Shaffer, Nathan D. Nguyen, Olutoyin A. Olutoye, Keziah M. Vargas, Eric C. Cheon

    Was not provided for this article.

  • Open Access

    Factors Influencing Research Output Among Pediatric Anesthesiologists: A 2‐Year Analysis

    by Rohan Bhardwaj, Lav Patel, Rachelle Liu, Sachin Govind, Kiara Moore, Chunyi Wu, Jillian DiBiase, Vidya Chidambaran, Eric C. Cheon

  • Open Access

    Risk Factors for Postoperative Pulmonary Compromise in a Pediatric Population: A Retrospective Review of a Single Institution Cohort

    by Alison Robles, Mehul V. Raval, Chunyi Wu, Heather A. Ballard, Mitchell Phillips, Nicholas E. Burjek, Eric C. Cheon

    Background/Objectives: Pediatric postoperative pulmonary complication is a major event associated with increased in-hospital morbidity and mortality. However, data is limited regarding the specific timing and spectrum of postoperative pulmonary complications in the pediatric population. Utilizing data in a cohort of high-risk patients aged ≤ 6 years, we sought to evaluate the timing and incidence of a composite of postoperative pulmonary complications. We hypothesized that ASA physical status, emergent case type, and procedure duration would be associated with pulmonary complications in high-risk children and that these complications would, in turn, be associated with a prolonged length of stay. Methods: Data from patients ≤ 6 years of age who were intubated for major abdominal surgery at the authors’ institution were collected from 1 January 2019 to 28 March 2022. The primary outcome was postoperative pulmonary complication, defined as the occurrence/use of reintubation, non-invasive positive pressure ventilation, high-flow nasal cannula, mask, or nasal cannula beyond phase 1 of recovery after anesthesia and within 7 postoperative days. The secondary outcome was hospital length of stay. We performed multivariable logistic regression with backward selection to identify independent predictors for postoperative pulmonary complications after adjusting for covariates. For hospital length of stay, a multivariate linear regression model was used after adjusting for covariates. Results: A total of 88 (26.1%) patients experienced 117 occurrences of postoperative oxygen dependence events, and 80 (90.9%) experienced this event in the first 48 h after surgery. The results of this model demonstrated independent associations between patients with an ASA class of IV (OR 9.86, 95% CI: 1.22–79, p-value = 0.03202) and longer operative time (OR: 1.05, 95% CI: 1.03–1.08, p = 0.00001) and postoperative pulmonary complication. On adjusted analysis, the occurrence of a postoperative pulmonary complication was associated with prolonged postoperative length of stay (adjusted geometric mean ratio of 1.39 (95% CI 1.10–1.75, p = 0.0062). Conclusions: Pediatric postoperative pulmonary complication remains a significant event for many patients and results in a prolonged length of stay. This study lays the groundwork for further investigations of interventions targeted at optimizing and monitoring at-risk individuals.


  • Effect of regional anesthesia on discharge opioid prescription practices following pediatric interventional radiology sclerotherapy: A follow up study

    by Joseph Ness, Alina Lazar, Angelica A. Vargas, Chunyi Wu, Eric C. Cheon, Jordan I. Gaelen, Shankar Rajeswaran

    ## Introduction The peri-procedural opioid-sparing effect of regional anesthesia during pediatric interventional radiology (IR) sclerotherapy for bone cysts, venous malformations, and lymphatic malformations has been demonstrated, though its impact on post-discharge opioid prescribing remains unclear. ## Materials and Methods A retrospective study was originally conducted at a single tertiary-care children’s hospital examining the analgesic utility of nerve blocks during IR-performed sclerotherapy for these indications between January 2016 and May 2025. Venous and lymphatic malformations were combined for final analysis. Data on discharge opioid prescriptions were obtained through the Illinois Prescription Monitoring Program and re-analyzed for predictive factors. ## Results 482 patients were included in final analysis. 189 (39.2%) received opioids at discharge, primarily hydrocodone-acetaminophen (98.9%). Adjusted logistic regression revealed a significantly increased odds of receiving an opioid prescription if in the non-block group (OR 3.01, 95% CI 1.95 to 4.68, p<0.001). Additionally, patients who did not receive a block were more likely to receive both higher doses (geometric mean ratio 1.54, 95% CI 1.31 to 1.81, p<0.001), and a greater number of doses (geometric mean ratio 1.87, 95% CI 1.50 to 2.33, p<0.001) compared to patients who did receive a nerve block. ## Discussion The use of regional anesthesia in pediatric IR for outpatient sclerotherapy for bone cysts, venous malformations, and lymphatic malformations was associated with a significant opioid-sparing effect that continued beyond the acute hospitalization into discharge. Enhanced Recovery After Surgery protocol development in IR would likely benefit from the early implementation of nerve block use.

  • Open Access

    Reduction in Perioperative Risk in Patients with Spinal Muscular Atrophy Following the Release of Disease-Modifying Therapies: An Analysis of the National Surgical Quality Improvement Program Database

    by Erin Toaz, Nisha Pinto, Keith Kilner, Eric Cheon

    Background/Objectives: Spinal muscular atrophy (SMA) is a progressive neurodegenerative disease resulting in proximal muscle weakness and paralysis. SMA treatment has radically changed in the past 10 years thanks to the development of novel therapies such as nusinersen and onasemnogene abeparvovec. Since the advent of new treatments, the incidence and perioperative risk factors of patients with SMA undergoing longer, higher-risk surgeries are unknown. We hypothesized that patients with SMA would be at an overall elevated risk for postoperative pulmonary complications (PPC) and prolonged length of stay compared to the general population, but that this would be reduced in patients undergoing surgery in the years after the release of new therapies. Methods: Patients who underwent surgery at a continuously enrolled American College of Surgeons National Surgery Quality Improvement Program-Pediatric hospital from 1 January 2012, to 31 December 2021, were included in this study. Cases with missing covariate or primary outcome data were excluded from the analysis. Patients with ages greater than 17 years, preoperative tracheostomy, preoperative mechanical ventilation, missing covariate or primary outcome data were excluded. Patients with SMA were identified by their ICD-9 and 10 codes. A cutoff year of 2018 was chosen for analysis of the primary outcomes as this was a full year after nusinersen received FDA approval. Results: On univariable analysis, the risk for PPC in patients with SMA was reduced in patients undergoing surgery in 2018 or later compared to pre-2018 (pre-2018 OR 4.44, 95% CI 1.56–9.6, p = 0.008; post-2018 OR 3.48, 95% CI 0.84–9.12, p = 0.08). On multivariable analysis, the association between SMA and PPC substantially decreased in 2018 and after but was no longer statistically significant (pre-2018 OR 1.96, 95% CI 0.80–4.80, p = 0.14; post-2018 OR 1.03, 95% CI 0.33–3.26, p = 0.96). SMA was positively associated with LOS in the pre-2018 cohort, with a coefficient from a log linear model of 0.67 (95% CI 0.32–1.01; p < 0.001), and SMA adding an additional 1.93 days in LOS. For data post-2018, the effect of SMA on LOS was no longer statistically significant. Conclusions: Utilizing a large dataset, we found a reduced association between SMA and PPC a year following widespread implementation of SMN antisense oligonucleotide therapy, and a statistically significant reduction in LOS in patients with SMA after 2018. This may reflect improved motor outcomes and respiratory mechanics in the new treatment era.


  • Continuing Anesthesia Services in the Face of a Prolonged Digital Health System Outage

    by Eric C. Cheon, Samantha B.S. Shaffer, Kailey M.S.N. McCarthy, Olga Leavitt, Shivali M.S. Mukerji, Courtney M.D. Hardy

    In today’s digitized healthcare environment, electronic health records (EHRs) and other electronic systems are key to daily hospital operations, patient care, and compliance. The authors’ institution underwent a prolonged EHR system outage that caused the Department of Pediatric Anesthesiology to rely on established downtime procedures. While the intraoperative EHR is lost, this is only one of many domains that can be affected by an outage. In fact, all aspects of care, from patient identification materials to operating room schedules to in-house communication, can be significantly affected. Anesthesia providers must be ready to revert to preestablished downtime protocols to continue safe care while also maintaining financial sustainability. The following narrative review details the department’s operational responses and outlines how safe and quality health care continued to be delivered, providing recommendations for other hospitals that may face similar challenges.


  • Open Access

    Perioperative Complications in Children with Down Syndrome: A Single Center Retrospective Analysis—Original Clinical Research Report

    by Michelle Tsao, Frank Yanko, Eric Cheon

    Background/Objectives: Down syndrome (DS) is the most common chromosomal abnormality in live births in the United States. Children with DS often require anesthesia for surgery or diagnostic imaging in their lives. These children present a unique perioperative risk profile due to a combination of anatomic and physiological alterations, along with associated comorbid conditions. There are limited studies on the perioperative outcomes of children with DS. This retrospective study assesses perioperative complications in pediatric patients with DS undergoing non-cardiac surgery or diagnostic imaging under anesthesia at a single tertiary pediatric hospital. Methods: The electronic medical record at a tertiary pediatric hospital was queried for children with DS who received anesthesia for non-cardiac surgery or diagnostic imaging from May 2016 to April 2021. The primary outcomes were complications defined as readmission, reoperation, or unexpected respiratory, cardiovascular, neurologic, surgical, or gastrointestinal issues. Exclusion criteria were cardiac surgery, age > 18 years, and records with incomplete or missing data. Results: A total of 1713 anesthetic records from 711 unique patients over five years were included in the final analysis. The study found a low overall complication rate (2.98%), with respiratory events being the most common (43.1%). While most complications are short term and resolved with treatment and time; there were also several severe, life-threatening complications. Increased procedural complexity, multiple procedures, and increased procedure duration were associated with higher complication rates, whereas patient age, sex, weight, and case urgency were not associated with higher complication rates. Conclusions: Children with DS often have comorbid conditions and require multiple life-improving surgeries. Our study found the perioperative complication rate for children with Down syndrome receiving anesthesia for non-cardiac surgery or diagnostic imaging is low, comparable to the general pediatric population. The findings indicate that anesthesia is well tolerated by children with DS. However, given patients’ unique anatomic and physiological differences, careful perioperative risk assessment and planning is essential. Clinical Implications: (a) What is already known about the topic: Pediatric patients with DS often require anesthesia for surgical procedures or medical imaging. They have anatomic and physiological alterations and comorbid conditions that may influence perioperative risk. (b) What new information this study adds: In a retrospective study at a tertiary pediatric hospital, patients with DS were found to have a low overall complication rate after anesthesia for non-cardiac surgery or diagnostic imaging. Increased procedural complexity, multiple procedures, and increased procedure duration were associated with higher complication rates.


  • Open Access

    BIS Guided Titration of Sevoflurane in Pediatric Patients Undergoing Elective Surgery: A Randomized Controlled Trial

    by T. Wesley Templeton, Gijo Alex, Jean D. Eloy, Lindsay Stollings, Richard J. Ing, Eric C. Cheon, Kumar Belani, Ilan Breskin, Peter S. Sebel, Brad M. Taicher, et al.

    Background: In pediatric patients, the use of processed EEG monitoring may reduce the amount of anesthesia administered while maintaining adequate depth of anesthesia.Aims: The primary aim of this study was to evaluate whether use of a BIS monitor to guide sevoflurane administration might reduce the average end tidal sevoflurane concentration used in children 4–18 years of age.Methods: Participants in three age groups (4–8, 9–12, and 13–18 years) were randomized to either the BIS guided group or the control group. Use of sevoflurane as the primary maintenance anesthetic was the only requirement in both arms. In the BIS guided group, sevoflurane was titrated to achieve a target BIS value of 45–60 during the maintenance period. In the control arm, clinicians were blinded to the BIS value. Primary outcome was mean end‐tidal sevoflurane concentration during maintenance phase of anesthesia. Secondary assessments included time to discharge and the readiness and quality of recovery as assessed by the Pediatric Anesthesia Emergence Delirium scale, the modified Aldrete Score, and the Wong–Baker FACES scale. An intention‐to‐treat analysis was used to analyze and compare groups.Results: A total of 180 participants were randomized. Following randomization, 10 participants did not undergo any study procedures, leaving 84 participants in the BIS guided group and 86 participants in the control group. Across all age groups, the average end‐tidal sevoflurane concentration was less in the BIS guided group compared to control (4–8 years: 2.2% ± 0.3% vs. 2.4% ± 0.4%, −0.3% [−0.4%, −0.1%]; 9–12 years: 1.7% ± 0.5% vs. 2.1% ± 0.6%, −0.4% [−0.7%, −0.1%]; 13–18 years: 1.6% ± 0.4% vs. 1.9% ± 0.5%, −0.3% [−0.5%, −0.1%]). No differences in recovery outcomes between treatment groups were observed.Conclusions: In pediatric participants, the BIS guided group reported a lower average end‐tidal sevoflurane concentration compared to control, though no significant differences in recovery profile were noted.Clinical Implications: The Bispectral Index (BIS) is a processed EEG tool that can be used to titrate general anesthesia to achieve desired anesthetic depth. Brain monitoring with BIS resulted in lower average end‐tidal sevoflurane concentrations in children aged 4–18 years undergoing general anesthesia.Trial Registration: ClinicalTrials.gov identifier: NCT04810481


  • Utilizing National Surgical Quality Improvement Program-Pediatric for Assessing Anesthesia Outcomes

    by Eric C. Cheon, Mehul V. Raval, Alexander Froyshteter, Hubert A. Benzon